ISRCTN68222771 : Efficacy of agomelatine given orally on the quality of remission in elderly depressed patients, after a 12-week treatment period. A randomised, double-blind, flexible-dose international multicentre study with parallel groups versus SSRI drug. Twelve-week treatment plus optional continuation for 12 weeks.
- Overall trial status
- Recruitment status
- No longer recruiting
Mental and Behavioural Disorders